The price of a vaccine that helps babies fight off killer diseases has been forced down, thanks to a co-ordinated buying policy to meet the growing demand from developing countries, according to a U.N.-backed health alliance' report.
Starting next year an extra 6.3 million children worldwide will have the chance to get vaccinated against some of the world's deadliest illnesses.
The funding will come from a drop in the price of the one-shot vaccine that safeguards against five infectious diseases to below $3 a dose, nearly 50 cents cheaper than this year, the alliance said.
It has been able to negotiate cheaper vaccine prices through competition created by rising demand for the shots. About half of the vaccines purchased by the alliance were produced in developing countries such as India.
"We know that immunization will start children having healthy lives," former Irish President Mary Robinson, board chair of the alliance, said as she watched the babies being immunized in Hanoi's Tan Hong Commune Heath Center. "We also know that, unfortunately, in the world there are ... children who don't get any vaccines so they die early. It is tragic because we can prevent it."
As a result of not receiving routine vaccinations, about 2 million children die annually.
The pentavalent vaccine protects against diphtheria, tetanus, pertussis, pneumonia, hepatitis B and Hib, which causes meningitis and pneumonia.
The GAVI Alliance, with partners ranging from U.N. agencies to the Bill & Melinda Gates Foundation, has vaccinated about 256 million poor children since 2000.
The Gates Foundation was created in 2000 by the Microsoft chairman and his wife, according to the Associated Press' report.